NYSE:EW
Edwards Lifesciences Corporation Stock News
$89.78
+0.640 (+0.718%)
At Close: May 20, 2024
These Are the Top 10 Holdings of David Rolfe
08:02pm, Tuesday, 04'th Oct 2022
David A. Rolfe is the chief investment officer at Wedgewood Partners and has been managing Wedgewood's portfolio for 18 years.
Stocks To Watch: Big Events For Tesla, Amazon And Intel
01:08am, Saturday, 24'th Sep 2022 Seeking Alpha
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week
What 8 Analyst Ratings Have To Say About Edwards Lifesciences
01:18pm, Thursday, 22'nd Sep 2022 Benzinga
Within the last quarter, Edwards Lifesciences (NYSE:EW) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
4
3
1
0
0
Las
HC Wainwright Cuts Price Target On This Stock By 50%? Also This Analyst Slashes PT On Cisco
12:20pm, Thursday, 22'nd Sep 2022 Benzinga
Barclays cut the price target on Cisco Systems, Inc. (NASDAQ: CSCO) from $56 to $46. Barclays analyst Tim Long downgraded the stock from Overweight to Equal-Weight. Cisco shares rose 0.1% to $41.61
Edwards Lifesciences (EW) Debuts SAPIEN 3 Ultra RESILIA Valve
03:26pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Edwards Lifesciences' (EW) SAPIEN 3 Ultra RESILIA valve combines its breakthrough RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve.
Edwards Lifesciences (EW) Debuts SAPIEN 3 Ultra RESILIA Valve
12:47pm, Tuesday, 13'th Sep 2022
Edwards Lifesciences' (EW) SAPIEN 3 Ultra RESILIA valve combines its breakthrough RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve.
Edward Lifesciences (EW) Gains From New Products Amid Cost Woe
03:58pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
Edwards Lifesciences (EW) expects full-year 2022 underlying sales to grow on the back of strength in demand for products used in more intense surgeries.
Edward Lifesciences (EW) Gains From New Products Amid Cost Woe
01:33pm, Wednesday, 07'th Sep 2022
Edwards Lifesciences (EW) expects full-year 2022 underlying sales to grow on the back of strength in demand for products used in more intense surgeries.
OCPNY or EW: Which Is the Better Value Stock Right Now?
03:40pm, Tuesday, 06'th Sep 2022 Zacks Investment Research
OCPNY vs. EW: Which Stock Is the Better Value Option?
OCPNY or EW: Which Is the Better Value Stock Right Now?
12:47pm, Tuesday, 06'th Sep 2022
OCPNY vs. EW: Which Stock Is the Better Value Option?
Edwards Lifesciences Best Able to Withstand Medtech Slowdown, Says Analyst
03:52pm, Monday, 22'nd Aug 2022
Investors do not seem convinced that Edwards Lifesciences Corp. ( EW , Financial) is well equipped to handle a downturn in the medical device industry. Despite what one analyst thinks, the Irving, Cal
Edwards Lifesciences (EW) Gets CE Mark for PASCAL Precision
04:44pm, Thursday, 18'th Aug 2022 Zacks Investment Research
Edwards Lifesciences' (EW) PASCAL Precision system enables precise navigation and implant delivery during mitral and tricuspid regurgitation treatment.
Edwards Lifesciences (EW) Gets CE Mark for PASCAL Precision
02:18pm, Thursday, 18'th Aug 2022
Edwards Lifesciences' (EW) PASCAL Precision system enables precise navigation and implant delivery during mitral and tricuspid regurgitation treatment.
Top Buys From The Best Money Managers (Q2 2022)
11:30am, Wednesday, 17'th Aug 2022 Seeking Alpha
I curated a list of some high-profile hedge funds and looked into their holdings at the end of June 2022. See the top buys from best money managers during Q2.
Edwards Lifesciences (EW) Q2 Earnings Meet Estimates, Margins Up
05:54pm, Friday, 29'th Jul 2022 Zacks Investment Research
Edwards Lifesciences (EW) posts Q2 earnings in line with the Zacks Consensus Estimate, with robust performances across all product groups driving the top line.
